RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 3 | -99.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 459 | -83.7% | 0.00% | – |
| Q1 2022 | $16,000 | -51.5% | 2,822 | -16.6% | 0.00% | – |
| Q4 2021 | $33,000 | -56.0% | 3,385 | +9.7% | 0.00% | – |
| Q2 2021 | $75,000 | -9.6% | 3,087 | -0.9% | 0.00% | – |
| Q1 2021 | $83,000 | -49.4% | 3,116 | -85.5% | 0.00% | – |
| Q4 2020 | $164,000 | +4000.0% | 21,536 | +2976.6% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 700 | -14.7% | 0.00% | – |
| Q1 2020 | $4,000 | -87.9% | 821 | -76.1% | 0.00% | – |
| Q4 2019 | $33,000 | +725.0% | 3,430 | +518.0% | 0.00% | – |
| Q3 2019 | $4,000 | +100.0% | 555 | +270.0% | 0.00% | – |
| Q4 2018 | $2,000 | -81.8% | 150 | -66.0% | 0.00% | – |
| Q3 2018 | $11,000 | – | 441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $20,554,000 | 22.50% |
| Flagship Pioneering Inc. | 38,296,526 | $300,628,000 | 16.44% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,747,000 | 3.22% |
| Artal Group S.A. | 2,833,791 | $22,246,000 | 0.89% |
| EcoR1 Capital, LLC | 260,152 | $2,042,000 | 0.26% |
| Cormorant Asset Management, LP | 491,700 | $3,860,000 | 0.24% |
| Nikko Asset Management Americas, Inc. | 1,456,842 | $11,436,000 | 0.20% |
| ARK Investment Management | 730,890 | $5,737,000 | 0.12% |
| Leap Investments LP | 16,300 | $128,000 | 0.06% |
| Baillie Gifford | 4,240,767 | $33,290,000 | 0.04% |